MGNX MACROGENICS INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Thu 12 Nov 2026 · estimated
What 10 analyst firms say about MACROGENICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
9 rated views · 10 analyst/firm records · 10 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 4 reports on MGNX from 3 analyst firms in the last 90 days (10 firms in the past year).
Comparing each firm's latest target with its previous one: 2 left it unchanged.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: B. Riley Securities raised its target from $9.00 (set 10 Apr 2026) to $11.00 on 14 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Mayank Mamtani | Buy | 17 Aug 2026 | 11.00 USD |
| Barclays | Etzer Darout | Buy | 17 Aug 2026 | 6.00 USD |
| Citigroup | Unnamed analyst | Buy | 23 Oct 2026 | — |
| Citizens JMP | Silvan C Tuerkcan | Hold | 1 Jul 2026 | — |
| Evercore ISI | Jonathan Miller | Buy | 1 Jul 2026 | — |
| H.C. Wainwright | Robert Burns | Hold | 7 May 2026 | — |
| Leerink Partners | Jeffrey La Rosa | Buy | 1 Jul 2026 | 11.00 USD |
| TD Cowen | Tara Bancroft | Hold | 24 Mar 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 5 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 1 Jan 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:28 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.